Clinical Trial Update: Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors [Phase 4]

View source ↗

Summary

Phase 4 safety and efficacy study of bosutinib in Philadelphia chromosome-positive chronic myeloid leukemia patients previously treated with at least one tyrosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Chronic Myeloid Leukemia

Drugs mentioned

• Bosutinib (bosutinib)

Snippet

Sponsor: Pfizer | Conditions: Previously Treated PH + CML | Phase 4 | Status: TERMINATED | Results posted: 2021-12-30